Slow elimination of mannitol from human cerebrospinal fluid

European Journal of Clinical Pharmacology

Volumn 53, Issue 3-4, 1997, Pages 271-274

  Nau, R ^a   Desel, H ^a   Lassek, C ^a   Thiel, A ^a   Schinschke, S ^a   Rossing R ^a   Kolenda, H ^a   Prange, H W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cerebrospinal fluid; Mannitol

Indexed keywords

DEXAMETHASONE; MANNITOL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN EDEMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; STROKE;

AGED; FEMALE; HALF-LIFE; HUMANS; MALE; MANNITOL; MIDDLE AGED;

EID: 0031445702     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050375     Document Type: Article

References (22)

1. Wise BL, Chater N (1962) The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19: 1038-1043
2. Muizelaar JP, Lutz HA, Becker DP (1984) Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 61: 700-706
3. Haden RL (1919) Therapeutic application of the alteration of brain volume by the intravenous injection of glucose. JAM Assoc 73: 983-984
4. Weed LH, McKibben PS (1919) Pressure changes in the cerebrospinal fluid following intravenous injections of solutions of various concentrations. Am J Physiol 48: 512-530
5. Frank JI (1995) Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 45: 1286-1290
6. Anderson P, Boreus L, Gordon E, Lagerkranser M, Rudehill A, Lindquist C, Öhmann G (1988) Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels. Eur J Clin Pharmacol 35: 643-649
7. Rudehill A, Gordon E, Öhman G, Lindqvist C, Anderson P (1993) Pharmacokinetics and effect of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surnery. J Neurosurg Anesthesiol 5: 4-12
8. Benet LZ, Mitchell JR, Sheiner LB (1990) Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Gilman AG, Rail TW, Nies AS, Taylor P (eds) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Pergamon Press, New York, pp 3-32
9. Sawehuk RJ, Hedaya MA (1990) Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid. Pharm Res 7: 332-338
10. Nau R, Dreyhaupt T, Kolenda H, Prange HW (1992) Low blood to cerebrospinal fluid passage of sorbitol after intravenous infusion. Stroke 23: 1276-1279
11. Nau R, Prins FJ, Kolenda H, Prange HW (1992) Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur J Clin Pharmacol 42: 181-185
12. Allgen L-G, Norlen H, Kolmert T, Berg K (1987) Absorption and elimination of mannitol solution when used as an isotonic irrigating agent in connection with transurethral resection of the prostate. Stand J Urol Nephrol 21: 177-184
13. Norlen H, Allgen L-G, Wicksell B (1986) Mannitol concentrations in blood plasma in connection with transurethral resection of the prostate using mannitol solution as an irrigating fluid. Scand J Urol Nephrol 20: 119-126
14. O'Brien MM, Schofield PJ, Edwards MR (1983) Polyol-pathway enzymes of human brain: partial purification and properties of sorbitol dehydrogenase. Biochem J 211: 81-90
15. Sloviter HA, Shimkin P, Suhara K (1966) Glycerol as a substrate for brain metabolism. Nature 210: 1334-1336
16. Nau R, Zysk G, Thiel A, Prange HW (1993) Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Eur J Clin Pharmacol 45: 469-475
17. Reesor C, Chow AW, Kureishi A. Jewesson PJ (1988) Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts. J Infect Dis 158: 1142-1143
18. 14-labelled mannitol from serum into cerebrospinal fluid and brain. Exp Neurol 10: 264-270
19. Kaufmann GE, Cardoso ER (1992) Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 77: 584-589
20. Fishman RA, Ransohoff J, Osserman EF (1958) Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest 37: 1419-1428
21. Blaney SM, Daniel MJ, Harker AJ, Godwin K, Balis FM (1995) Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates. Antimicrob Agents Chemother 39: 2779-2782
22. Nau R, Prange HW (1996) Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics. Eur J Clin Pharmacol 49: 407-409